Lite Strategy, Inc. (LITS) vs Instil Bio, Inc. (TIL)
A side-by-side comparison of Lite Strategy, Inc. and Instil Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LITS
Lite Strategy, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 2:54 PM EDT
TIL
Instil Bio, Inc.
$6.90HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT
Total return — LITS vs TIL
growth of $100 · dividends reinvested · last 1yLITS -69.1% (-69.1%/yr)TIL -76.2% (-76.2%/yr)LITS compounded faster over this window
LITS TIL
LITS vs TIL: by the numbers
- •LITS is the larger company ($48M vs $47M market cap).
Metrics side by side
Valuation
| Metric | LITS | TIL |
|---|---|---|
| P/B ratio | 1.15 | 0.44 |
Profitability
| Metric | LITS | TIL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -170.94% | -28.20% |
| ROIC | -30.75% | -18.61% |
Growth (annualized)
| Metric | LITS | TIL |
|---|---|---|
| Total return CAGR (5Y) | N/A | -54.60% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.